Table 3.
Comparison of FMF with amyloidosis, amyloidosis-free FMF, and controls in terms of leucocyte, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and neutrophil/lymphocyte ratio (NLR) values.
| FMF with amyloidosis n = 12 (mean ± SD) |
FMF without amyloidosis n = 82 (mean ± SD) |
Controls n = 60 (mean ± SD) |
P 1 | P 2 | P 3 | |
|---|---|---|---|---|---|---|
| Leucocyte, ×109/L | 8.35 ± 2.58 | 7.19 ± 1.75 | 6.81 ± 1.43 | 0.084 | 0.068 | 0.158 |
| ESR, mm/h | 24.00 ± 15.89 | 9.83 ± 8.42 | 6.40 ± 4.13 | <0.0001 | 0.016 | 0.006 |
| CRP, mg/L | 4.42 ± 2.24 | 3.04 ± 2.08 | 2.43 ± 1.57 | 0.191 | 0.059 | 0.090 |
| NLR, % | 2.51 ± 0.62 | 1.99 ± 0.58 | 1.59 ± 0.42 | 0.009 | <0.0001 | <0.0001 |
P 1: P value comparison between FMF with amyloidosis and FMF without amyloidosis.
P 2: P value comparison between FMF with amyloidosis and healthy controls.
P 3: P value comparison between FMF without amyloidosis and healthy controls.